Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Optinose Inc (OPTN)
NASDAQ:OPTN
Optinose (OPTN) Stock Price & Analysis
441 Followers
OPTN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.80 - $2.10
Previous Close$1.05
Volume249.26K
Average Volume (3M)1.27M
Market Cap
$150.63M
Enterprise Value$229.64M
Total Cash (Recent Filing)$51.64M
Total Debt (Recent Filing)$130.65M
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Aug 08, 2024EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding113,038,726
10 Day Avg. Volume640,557
30 Day Avg. Volume1,268,022
Standard Deviation0.23
R-Squared0.00098
Alpha-0.00551
Financial Highlights & Ratios
Price to Book (P/B)-1.24
Price to Sales (P/S)6.20
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.10
Enterprise Value/Gross Profit3.68
Enterprise Value/Ebitda-26.21
Forecast
1Y Price Target
$5.00Price Target Upside376.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Optinose News
Ownership Overview
5.23% Insiders
11.76% Mutual Funds
35.09% Other Institutional Investors
47.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
OPTN FAQ
What was Optinose Inc’s price range in the past 12 months?
Optinose Inc lowest stock price was $0.80 and its highest was $2.10 in the past 12 months.
What is Optinose Inc’s market cap?
Currently, no data Available
When is Optinose Inc’s upcoming earnings report date?
Optinose Inc’s upcoming earnings report date is Aug 08, 2024 which is in 35 days.
How were Optinose Inc’s earnings last quarter?
Optinose Inc released its earnings results on May 14, 2024. The company reported -$0.12 earnings per share for the quarter, missing the consensus estimate of -$0.106 by -$0.014.
Is Optinose Inc overvalued?
According to Wall Street analysts Optinose Inc’s price is currently Undervalued.
Does Optinose Inc pay dividends?
Optinose Inc does not currently pay dividends.
What is Optinose Inc’s EPS estimate?
Optinose Inc’s EPS estimate is -$0.08.
How many shares outstanding does Optinose Inc have?
Optinose Inc has 144,838,730 shares outstanding.
What happened to Optinose Inc’s price movement after its last earnings report?
Optinose Inc reported an EPS of -$0.12 in its last earnings report, missing expectations of -$0.106. Following the earnings report the stock price went down -3.419%.
Which hedge fund is a major shareholder of Optinose Inc?
Among the largest hedge funds holding Optinose Inc’s share is Oracle Investment Management Inc. It holds Optinose Inc’s shares valued at 475K.
---
Optinose Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (376.19% Upside)
$5.00 (376.19% Upside)
Blogger Sentiment
Bullish
OPTN Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 84.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.22%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-27.16%
Trailing 12-Months
Company Description
Optinose Inc
OptiNose, Inc. is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
---
OPTN Company Deck
---
OPTN Earnings Call
Q1 2024
0:00 / 0:00
---
OPTN Stock 12 Month Forecast
Average Price Target
$5.00
▲(376.19% Upside)
Technical Analysis
Aptose Biosciences
―
Palatin Technologies
―
Avadel Pharmaceuticals
―
Protagonist Therapeutics
―
Best Analysts Covering OPTN
1 Year
1 Year Success Rate
2/17 ratings generated profit
1 Year Average Return
-41.31%
reiterated a buy rating 4 months ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -41.31% per trade.
---